Bennett Carter

A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease.

Nupura S. Bhise, R. Kanasty, Andrew M. Bellinger, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Pharmaceutical development of IPI‐504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer

Denise A. Mayes, G. Sylvester, J. Adams, 2010 .

Pharmaceutical Development of IPI-504, an Aqueous Soluble Analog of 17-AAG and Potent Inhibitor of Hsp90

G. Sylvester, E. Holson, J. Helble, 2008 .

The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway

Jeanne A. Ferguson, J. Sydor, J. Adams, 2013, Xenobiotica; the fate of foreign compounds in biological systems.